Rain Enhancement Technologies Holdco, Inc. (RAIN:NASDAQ) closed at $0.503 on November 6, 2026, down 5.34% on the day. The stock trades 94.1% below its 52-week high of $8.52 and 0.6% above its 52-week low of $0.500. Over the past year, it lost 89.8%. Rain Enhancement Technologies Holdco, Inc. is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, RAIN closed higher on 96 days (38%). Its best day was September 22, 2026 (+54.31%) and its worst was December 31, 2025 (-28.17%). The stock moved 10% or more in a single session 45 times. It opened at least 5% above the previous day's high 4 times.
Rain Therapeutics Inc is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which they are able to genetically select patients they believe will most likely benefit. Its lead product candidate, RAIN-32 is a small molecule, oral inhibitor of mouse double minute 2, which is oncogenic in numerous cancers.
Find more stocks like RAIN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.